We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Always look at the bright side of drugs?
- Authors
Nygren, Peter
- Abstract
The author reflects on why data on the effects of cancer drugs from patient cohort studies and clinical trials are frequently over-interpreted and why preclinical cancer research findings are frequently not possible to reproduce. He mentions the improvement of median overall survival (OS) in drug treatment of metastatic colorectal cancer (mCRC). He discusses two randomised clinical trials on the benefits of bevacizumab in combination with chemotherapy in mCRC treatment.
- Subjects
CANCER chemotherapy; DRUG therapy; CONFERENCES &; conventions; TUMORS; DATA analysis; RANDOMIZED controlled trials
- Publication
Acta Oncologica, 2015, Vol 54, Issue 2, p145
- ISSN
0284-186X
- Publication type
Article
- DOI
10.3109/0284186X.2014.1001874